MZE829 — Topline data
Sep 2026–Apr 2027
Enrollment in Phase 2 HORIZON trial of MZE829 on track; data from all cohorts expected in late 2026 or early 2027Source filing
MAZE biotech catalysts & pipeline
MAZE THERAPEUTICS INC · Data as of 2026-09-08
Upcoming catalysts
MZE782 — Topline data
2027
Phase 2 CIPheR trial of MZE782 in PKU initiated and enrollment ongoing; topline data expected in 2027Source filing